Bacchus Vascular infusion catheter
This article was originally published in The Gray Sheet
Executive SummaryCompany introduces its next-generation Trellis-8 drug infusion catheter at the Society of Interventional Radiology meeting in New Orleans April 1. The device is indicated for percutaneous treatment of deep vein thrombosis through "isolated thrombolysis," or "targeted delivery and increased penetration of clot-dissolving drugs into a blood clot," according to Bacchus. The firm plans to modify Trellis-8 to treat other vascular occlusive diseases in the near future...
You may also be interested in...
TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.